Movement Alert｜Oscar Health, Inc. Intraday Rise 5.19% in Regular Trading, UBS Raises Price Target as Q3 Upside Seen More Limited

Market Focus04:23

On November 4, Oscar Health, Inc. rose 5.19% in Regular Trading, trading at $32.61 per share, with turnover of $77.3092 million.

The move followed recent analyst commentary indicating that updated guidance already reflects favorable medical utilization trends, while UBS raised its price target to $36 from $26 and maintained a Neutral rating ahead of the company’s November 5 earnings release.

Further detail showed UBS lifted its EPS estimates for 2026 through 2028 to $2.00, $2.30, and $2.80, respectively. At the same time, the firm said upside in the third quarter may be less pronounced because the company’s revised outlook has already incorporated positive operating trends. UBS also noted that additional program integrity checks across a large member group and potential disenrollment could weigh on revenue, though the company suggested the impact could be absorbed within its outlook.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment